HRT
HRT After Hysterectomy
Oestrogen-only HRT, why progesterone is usually not needed, and dose considerations.
Without a uterus, progestogen is not required for endometrial protection in most cases. Some women still choose it for sleep or mood benefits — this guide explains when.
Around 1 in 5 UK women will have a hysterectomy by age 60 — for fibroids, heavy bleeding, endometriosis, prolapse or cancer risk reduction. HRT after hysterectomy is usually simpler than for women with a uterus: without an endometrium to protect, most women take oestrogen alone, without progestogen. But the details — surgical vs natural menopause, ovaries in or out, endometriosis history, breast cancer risk — change the prescription. Getting the regimen right after hysterectomy is one of the highest-leverage prescribing decisions in menopause care, because these women often need higher doses for longer and see the greatest quality-of-life gains.
Why progestogen is usually not needed
- The role of progestogen in HRT is to protect the endometrium from oestrogen-driven overgrowth (endometrial hyperplasia and cancer).
- Without a uterus, there is no endometrium — so no progestogen is required.
- Oestrogen-only regimens have a more favourable long-term breast cancer risk profile than combined regimens: WHI data actually show a slight reduction in breast cancer incidence and mortality with conjugated equine oestrogen alone.
When progestogen or Mirena is still considered
- History of significant endometriosis — residual endometrial tissue outside the uterus can respond to unopposed oestrogen and, rarely, undergo malignant change. Many specialists add continuous progestogen for 1–2 years post-op.
- Sub-total hysterectomy (cervix retained with a small endometrial stump) — combined HRT is usually indicated.
- Some women choose to take micronised progesterone (Utrogestan) at night for its sleep and mood-calming effects, even without a uterus.
Choosing the oestrogen route and dose
- Transdermal oestrogen is usually first choice — patches (Evorel, Estradot), gel (Oestrogel, Sandrena) or spray (Lenzetto).
- No increased VTE (blood clot) risk at standard transdermal doses; kinder to migraines, blood pressure and mood.
- Younger women after surgical menopause (bilateral oophorectomy under 45) typically need higher physiological doses — often 100–150 mcg patch or 4 pumps of Oestrogel — to replace what would otherwise be produced naturally.
- Tablet oestrogens (Elleste Solo, Premarin) remain an option for women who prefer them and have no clot or migraine risk factors.
Special case: bilateral oophorectomy under 45
- Surgical removal of both ovaries before natural menopause is a medical event with lifelong implications.
- Without HRT, these women have significantly higher rates of osteoporosis, cardiovascular disease, cognitive decline and premature mortality.
- NICE and BMS advise HRT until at least the natural age of menopause (~51) — this is treatment, not lifestyle choice.
- Higher doses are often needed to restore physiological levels — this is not a red flag, it is appropriate replacement.
- Testosterone should be discussed early — libido, energy and cognitive changes are common and treatable.
Testosterone and vaginal oestrogen after hysterectomy
- Testosterone deficiency is common after hysterectomy — especially if ovaries were removed. Baseline total testosterone and SHBG guide the discussion.
- Vaginal oestrogen for GSM is still frequently needed even on adequate systemic HRT — the vulva, vaginal opening and urethra often need local treatment.
- Both can safely be added to oestrogen-only HRT.
Monitoring and review
- 12-week review after starting or changing a regimen.
- Annual review thereafter: symptoms, blood pressure, breast awareness, weight, lifestyle.
- Blood tests are not routinely needed to prescribe HRT, but for women on high-dose or transdermal regimens after early surgical menopause we sometimes check oestradiol to confirm adequate absorption.
- DEXA scan around age 60, sooner if fragility risk factors present.
Common misconceptions
- ‘I had a hysterectomy so I can’t take HRT’ — usually the opposite is true; HRT is often simpler after hysterectomy.
- ‘I don’t need HRT because my ovaries were left in’ — ovarian function can decline after hysterectomy by 3–4 years earlier than natural menopause, so symptoms still emerge.
- ‘I can’t tell I’m in menopause because I don’t have periods’ — track symptoms, sleep, mood and libido; an FSH test can help in specific cases.
Key takeaway
No uterus usually means simpler HRT — oestrogen alone, transdermal, at whatever dose fully controls symptoms. For women after early surgical menopause, HRT until at least age 51 is not optional; it is standard care.
How Dr Awal approaches this in clinic
Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.
- A detailed 60 minute first appointment — no rushed 10-minute slots.
- Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
- Body-identical HRT considered first-line where appropriate.
- Shared-care letters sent to your NHS GP so treatment can continue affordably.
- Follow-up at 3 months to fine-tune your regimen and address side effects.
- Ongoing annual reviews so your plan evolves with you.
Common questions we hear about this
Do I need to be at a certain age to be seen?
No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.
Will my GP continue the prescription?
In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.
What if I've tried HRT before and it didn't suit me?
Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.
How long will I need to stay on treatment?
There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.
Where do you see patients?
All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.
About the author
Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.
Sources & further reading
General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.
Talk it through
Book a private consultation with Dr Awal
Get evidence-based, personalised advice on hrt after hysterectomy and any related concerns.
Related in HRT
Continue reading
A Comprehensive Guide to HRT
Types of HRT, oestrogen vs progesterone, benefits, side effects — and how to manage them.
Read guide
NHS vs Private HRT in the UK
How NHS and private HRT compare — costs, wait times, choice of preparations and how to transfer prescriptions.
Read guide
HRT Shortages in the UK
Why HRT supply issues happen, current UK availability and safe swaps if your prescription is unavailable.
Read guide